Original articles

• Hospital Mortality in 415 798 AMI Patients: 4 Years Earlier in the Canary Islands Than in the Rest of Spain

  Carmen Mate Redondo, María Cristo Rodríguez-Pérez, Santiago Domínguez Coello, Arturo J. Pedrero García, Itahisa Marcelino Rodríguez, Francisco J. Cuevas Fernández, Delia Almeida González, Buenaventura Brito Díaz, Marcos Rodríguez Esteban, Antonio Cabrera de León

  Rev Esp Cardiol. 2019;72:466-72

• Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II

  José R. López-Mínguez, Juan M. Nogales-Asensio, Eduardo Infante De Oliveira, Vasco De Gama Ribeiro, Rafael Ruiz-Salmerón, Dabit Arzamendi-Aizpurua, Marco Costa, Hipólito Gutiérrez-García, José Antonio Fernández-Díaz, Victoria Martín-Yuste, Juan Carlos Rama-Merchán, Raúl Moreno-Gómez, Amparo Benedicto-Buendía, Andrés Íñiguez-Romo

  Rev Esp Cardiol. 2019;72:449-55

• Impact of Percutaneous Coronary Revascularization of Severe Coronary Lesions on Secondary Branches

  Macarena Cano-García, Mercedes Millán-Gómez, Carlos Sánchez-González, Juan H. Alonso-Briales, Luz D. Muñoz-Jiménez, Fernando Carrasco-Chinchilla, Antonio Domínguez-Franco, Antonio J. Muñoz-García, Juan A. Bullones-Ramírez, Jesús M. Álvarez-Rubiera, Manuel de Mora-Martín, Eduardo de Teresa-Galván, José M. Hernández-García, Cristóbal A. Urbano-Carrillo, Manuel F. Jiménez-Navarro

  Rev Esp Cardiol. 2019;72:456-65

• A Global Assessment of Circulating Prolysyl Oxidase in Nonischemic Patients With Garden-variety Heart Failure With Preserved Ejection Fraction

  Benjamín Muñoz Calvo, Ana Villa Martínez, Susana López Orgil, Natalia López Andrés, Feliciano Román García, Virginia Víctor Palomares, Esther de la Calle de la Villa, Verónica Nadador Patiño, Ignacio Arribas-Gómez

  Rev Esp Cardiol. 2019;72:407-15

• Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

  Iñaki Lekuona, Manuel Anguita, José Luis Zamorano, José Manuel Rodríguez, Paloma Barja de Soroa, Ferran Pérez-Alcántara

  Rev Esp Cardiol. 2019;72:398-406

• Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry

  Ignacio J. Amat-Santos, Victoria Martin-Yuste, José Antonio Fernández-Díaz, Javier Martin-Moreiras, Juan Caballero-Borrego, Pablo Salinas, Soledad Ojeda, Fernando Rivero, Julio Núñez Villota, Mohsen Mohandes, Daniela Dubois, Francisco Bosa Ojeda, Eva Rumiz, José M. de la Torre Hernández, Jesús Jiménez-Mazuecos, Javier Lacunza, Paula Tejedor, Itziar Gómez, Luis R. Goncalves-Ramirez, Paol Rojas, Manel Sabaté, Javier Goicolea, Alejandro Diego Nieto, Miriam Jiménez-Fernández, Javier Escaned, Nieves Gonzalo, Laura Pardo, Javier Cuesta, Gema Miñana, Juan Sanchis, Sergio Rojas, Raúl Millán, Beatriz Vaquerizo, Sara Rodríguez, Dae-Hyun Lee, Francisco J. Morales, Alejandro Gutiérrez, María López, Jaume Maristany, Juan Rondán, Guillermo Galeote, Zuheir Kabbanni, Sergio Rodríguez, Luis Teruel, Mario Sadaba, Alfonso Jurado, ... Renato Fernandes

  Rev Esp Cardiol. 2019;72:373-82

• New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis

  Luigi Biasco, Dragana Radovanovic, Marco Moccetti, Hans Rickli, Marco Roffi, Franz Eberli, Raban Jeger, Tiziano Moccetti, Paul Erne, Giovanni Pedrazzini

  Rev Esp Cardiol. 2019;72:383-91

• Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention

  Hugo González Saldivar, Lourdes Vicent Alaminos, Carlos Rodríguez-Pascual, Gonzalo de la Morena, Covadonga Fernández-Golfín, Carmen Amorós, Mario Baquero Alonso, Luis Martínez Dolz, Albert Ariza Solé, Gabriela Guzmán-Martínez, Juan José Gómez-Doblas, Antonio Arribas Jiménez, María Eugenia Fuentes, Laura Galian Gay, Martín Ruiz Ortiz, Pablo Avanzas, Emad Abu-Assi, Tomás Ripoll-Vera, Oscar Díaz-Castro, Eduardo Pozo Osinalde, Eva Bernal, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2019;72:392-7

• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis

  Carlos Escobar, Julio Martí-Almor, Alejandro Pérez Cabeza, M. José Martínez-Zapata

  Rev Esp Cardiol. 2019;72:305-16

• Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish Family

  Paloma Nieto-Marín, Juan Jiménez-Jáimez, David Tinaquero, Silvia Alfayate, Raquel G. Utrilla, María del Mar Rodríguez Vázquez del Rey, Francesca Perin, Geòrgia Sarquella-Brugada, Lorenzo Monserrat, Josep Brugada, Luis Tercedor, Juan Tamargo, Eva Delpón, Ricardo Caballero

  Rev Esp Cardiol. 2019;72:324-32

• Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: The TRAINING-HF Trial

  Patricia Palau, Eloy Domínguez, Laura López, José María Ramón, Raquel Heredia, Jessika González, Enrique Santas, Vicent Bodí, Gema Miñana, Ernesto Valero, Anna Mollar, Vicente Bertomeu González, Francisco J. Chorro, Juan Sanchis, Josep Lupón, Antoni Bayés-Genís, Julio Núñez

  Rev Esp Cardiol. 2019;72:288-97

• Cell-free DNA and Microvascular Damage in ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

  Juan Sanchis, Sergio García-Blas, Luis Ortega-Paz, Ana Paula Dantas, Enrique Rodríguez, Lidia Abellán, Salvatore Brugaletta, Ernesto Valero, Gema Miñana, Manuel Garabito, África Corchón, Julio Núñez, Arturo Carratalá, Manel Sabaté

  Rev Esp Cardiol. 2019;72:317-23

• Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel

  Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D’Ascenzo, Saleta Fernández-Barbeira, Tim Kinnaird, Albert Ariza-Solé, Sergio Manzano-Fernández, Christian Templin, Lazar Velicki, Ioanna Xanthopoulou, Enrico Cerrato, Giorgio Quadri, Andrea Rognoni, Giacome Boccuzzi, Andrea Montabone, Salma Taha, Alessandro Durante, Sebastiano Gili, Giulia Magnani, Michele Autelli, Alberto Grosso, Pedro Flores Blanco, Alberto Garay, Ferdinando Varbella, Francesco Tommassini, Berenice Caneiro Queija, Rafael Cobas Paz, María Cespón Fernández, Isabel Muñoz Pousa, Diego Gallo, Umberto Morbiducci, Alberto Domínguez-Rodríguez, José Antonio Baz-Alonso, Mariano Valdés, Ángel Cequier, Fiorenzo Gaita, Dimitrios Alexopoulos, Andrés Íñiguez-Romo

  Rev Esp Cardiol. 2019;72:298-304

• Prognostic Value of Serum Lactate Levels in Patients Undergoing Urgent Heart Transplant: A Subanalysis of the ASIS-TC Spanish Multicenter Study

  David Couto-Mallón, Francisco González-Vílchez, Luis Almenar-Bonet, Beatriz Díaz-Molina, Javier Segovia-Cubero, José González-Costello, Juan Delgado-Jiménez, María A. Castel-Lavilla, María G. Crespo-Leiro, Diego Rangel-Sousa, Manuel Martínez-Sellés, Gregorio Rábago-Juan-Aracil, Luis De-la-Fuente-Galán, Teresa Blasco-Peiró, Daniela Hervás-Sotomayor, Iris P. Garrido-Bravo, Sonia Mirabet-Pérez, Javier Muñiz, Eduardo Barge-Caballero

  Rev Esp Cardiol. 2019;72:208-14

• The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency Department

  Òscar Miró, Xavier Rosselló, Víctor Gil, Francisco Javier Martín-Sánchez, Pere Llorens, Pablo Herrero, Javier Jacob, María Luisa López-Grima, Cristina Gil, Francisco Javier Lucas Imbernón, José Manuel Garrido, María José Pérez-Durá, María Pilar López-Díez, Fernando Richard, Héctor Bueno, Stuart J. Pocock

  Rev Esp Cardiol. 2019;72:198-207

• High-intensity Interval Training Dosage for Heart Failure and Coronary Artery Disease Cardiac Rehabilitation. A Systematic Review and Meta-analysis

  Ismael Ballesta García, Jacobo Ángel Rubio Arias, Domingo Jesús Ramos Campo, Ignacio Martínez González-Moro, María Carrasco Poyatos

  Rev Esp Cardiol. 2019;72:233-43

• Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension. Observational Study in a Referral Unit

  Maite Velázquez, Agustín Albarrán, Ignacio Hernández, M. Jesús López-Gude, Fernando Sarnago, Roberto Martín, Fernando Arribas, Pilar Escribano

  Rev Esp Cardiol. 2019;72:224-32

• Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome

  Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D’Ascenzo, Tim Kinnaird, Albert Ariza-Solé, Sergio Manzano-Fernández, Christian Templin, Lazar Velicki, Ioanna Xanthopoulou, Enrico Cerrato, Giorgio Quadri, Andrea Rognoni, Giacome Boccuzzi, Andrea Montabone, Salma Taha, Alessandro Durante, Sebastiano Gili, Giulia Magnani, Michele Autelli, Alberto Grosso, Pedro Flores Blanco, Alberto Garay, Ferdinando Varbella, Francesco Tomassini, Rafael Cobas Paz, María Cespón Fernández, Isabel Muñoz Pousa, Diego Gallo, Umberto Morbiducci, Alberto Domínguez-Rodríguez, José Antonio Baz-Alonso, Francisco Calvo-Iglesias, Mariano Valdés, Ángel Cequier, Fiorenzo Gaita, Dimitrios Alexopoulos, Andrés Íñiguez-Romo, Emad Abu-Assi

  Rev Esp Cardiol. 2019;72:215-23

• Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant

  Rebeca Lorca, Juan Gómez, María Martín, Rubén Cabanillas, Juan Calvo, Víctor León, Isaac Pascual, César Morís, Eliecer Coto, José Julián R. Reguero

  Rev Esp Cardiol. 2019;72:138-44

• Start-up of a Cardiology Day Hospital: Activity, Quality Care and Cost-effectiveness Analysis of the First Year of Operation

  María Gallego-Delgado, Eduardo Villacorta, M. Carmen Valenzuela-Vicente, Ángela Walias-Sánchez, Carmen Ávila, M. Jesús Velasco-Cañedo, M. Teresa Cano-Mozo, Agustín Martín-García, María Jesús García-Sánchez, Argelina Sánchez, Manuel Cascón, Pedro L. Sánchez

  Rev Esp Cardiol. 2019;72:130-7